EDITORIAL
Published on 15 Nov 2024
Editorial: Basic, clinical, and translational studies of Yao syndrome and other NOD2 related diseases
doi 10.3389/fimmu.2024.1521815
- 1,068 views
- Frontiers in Immunology
- Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
- Research Topics
- Basic, clinical, and translational studies of Yao syndrome and other NOD2 related diseases
Basic, clinical, and translational studies of Yao syndrome and other NOD2 related diseases
7,282
Total downloads
28k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 04 Oct 2024
Clinical phenotype, NOD2 genotypes, and treatment observations in Yao syndrome: a retrospective case series
doi 10.3389/fimmu.2024.1304792
- 2,874 views
- 1 citation
ORIGINAL RESEARCH
Published on 20 Sep 2024
Comprehensive clinical phenotype, genotype and therapy in Yao syndrome
doi 10.3389/fimmu.2024.1458118
- 3,690 views
- 3 citations
ORIGINAL RESEARCH
Published on 03 Sep 2024
Expanding clinical characteristics and genotypic profiling of Yao syndrome in Chinese patients
doi 10.3389/fimmu.2024.1444542
- 1,244 views
- 1 citation
ORIGINAL RESEARCH
Published on 29 Jan 2024
The expanding clinical spectrum of autoinflammatory diseases with NOD2 variants: a case series and literature review
doi 10.3389/fimmu.2024.1342668
- 3,503 views
- 7 citations
ORIGINAL RESEARCH
Published on 19 Oct 2023
Implications of combined NOD2 and other gene mutations in autoinflammatory diseases
doi 10.3389/fimmu.2023.1265404
- 4,872 views
- 16 citations
CASE REPORT
Published on 05 Oct 2023
Case Report: Methotrexate and hydroxychloroquine in combination for the treatment of NOD2-mutation-associated Blau syndrome
doi 10.3389/fimmu.2023.1279329
- 1,904 views
ORIGINAL RESEARCH
Published on 21 Jun 2023
Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome
doi 10.3389/fimmu.2023.1211240
- 2,544 views
- 9 citations
